title: Delayed remission after thymectomy for myasthenia gravis of the purely ocular type.
abstract: Twenty-two cases of purely ocular myasthenia gravis were reviewed to evaluate the long-term effects of thymectomy. Remission rate increased gradually with time (11.8% at 3 years, 23.1% at 5 years, and 33.3% at 10 years). Analysis of factors influencing remission with time showed that patients with short duration of illness attained remission significantly earlier (p = 0.035 at 5-year follow-up). One of 22 patients with purely ocular myasthenia gravis (4.5%) had disease progression. Because ocular myasthenia gravis often progresses to the generalized type and because duration of illness before operation is one of important factors influencing remission, we conclude that thymectomy in the earlier stages of the disease is the preferred treatment for ocular myasthenia gravis, just as for generalized myasthenia gravis.
authors: Second Department of Surgery, Tottori University Faculty of Medicine, Yonago, Japan.
authors: H
authors: H
authors: Nakamura
authors: Y
authors: Y
authors: Taniguchi
authors: Y
authors: Y
authors: Suzuki
authors: Y
authors: Y
authors: Tanaka
authors: K
authors: K
authors: Ishiguro
authors: M
authors: M
authors: Fukuda
authors: H
authors: H
authors: Hara
authors: T
authors: T
authors: Mori
mesh_terms: D000293:Adolescent; D000328:Adult; D000367:Age Factors; D002648:Child; D018450:Disease Progression; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008137:Longitudinal Studies; D008297:Male; D008875:Middle Aged; D009157:Myasthenia Gravis / Q000503:physiopathology / Q000601:surgery*; D009801:Oculomotor Muscles / Q000503:physiopathology*; D012074:Remission Induction; D012189:Retrospective Studies; D012737:Sex Factors; D013934:Thymectomy; D016896:Treatment Outcome